SAN LUIS OBISPO, Calif., June 16, 2021 /PRNewswire/ — Emerald Scientific, LLC has been accepted as an Industry Collaborator by the Consortium for Medical Marijuana Clinical Outcomes. Established in June 2019, the Consortium conducts, shares, and supports research on the effects of medical marijuana on health conditions and symptoms. Directed by a leadership team at
SAN LUIS OBISPO, Calif., June 16, 2021 /PRNewswire/ — Emerald Scientific, LLC has been accepted as an Industry Collaborator by the Consortium for Medical Marijuana Clinical Outcomes. Established in June 2019, the Consortium conducts, shares, and supports research on the effects of medical marijuana on health conditions and symptoms. Directed by a leadership team at the University of Florida, the Consortium engages public and private universities across the state of Florida to facilitate and conduct research on medical marijuana across the state to inform clinical care and policy.
As an Industry Collaborator, Emerald Scientific is listed in the Connect and Advance Research for Medical Marijuana Analysis (CARMMA) Database. The CARMMA Database was designed to connect key partnerships between researchers, physicians, and industry collaborators with the goal to increase and accelerate medical marijuana research. Access to the CARMMA Database can be requested on the Consortium’s website at mmjoutcomes.org.
